Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-11

FDA Approved: LEXETTE — Original Application (Mayne Pharma)

View source ↗

Summary

FDA approved Mayne Pharma's original application for halobetasol propionate under the brand LEXETTE.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEXETTE (HALOBETASOL PROPIONATE)

Snippet

ORIG AP for LEXETTE (HALOBETASOL PROPIONATE)